Ebolavirus Infections (Ebola Hemorrhagic Fever) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Ebolavirus Infections pipeline market report provides a comprehensive overview on the therapeutics under development for Ebolavirus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Ebolavirus Infections and features dormant and discontinued projects.
Key Targets in the Ebolavirus Infections Pipeline Drugs Market
In the Ebolavirus Infections pipeline drugs market the key targets are Glycoprotein, RNA Directed RNA Polymerase, Cell Membrane, Ebola virus Matrix Protein VP40, Niemann Pick C1 Protein, RNA, 70 kDa Ribosomal Protein S6 Kinase, Cathepsin B, Cathepsin L1, and Cells Expressing Phosphatidylserine.
Ebolavirus Infections Pipeline Drugs Market, by Targets
For more target insights, download a free report sample
Types of Key MoA in the Ebolavirus Infections Pipeline Drugs Market
Glycoprotein Inhibitor has the highest number of pipeline products followed by RNA Directed RNA Polymerase Inhibitor, Cell Membrane Disruptor, Niemann Pick C1 Protein Inhibitor, RNA Synthesis Inhibitor, 70 kDa Ribosomal Protein S6 Kinase Inhibitor, Cathepsin B Inhibitor, Cathepsin L1 Inhibitor, Cytotoxic To Cells Expressing Phosphatidylserine, and Ebola virus Matrix Protein VP40 Inhibitor.
Ebolavirus Infections Pipeline Drugs Market, by MoA
To get more insights on key MoA, download a free sample report
Ebolavirus Infections Pipeline Drugs Market Segmentation by RoA
The key routes of administration in the Ebolavirus Infections pipeline drugs market are intramuscular, intravenous, oral, inhalational, nasal, parenteral, subcutaneous, topical, intradermal, and sublingual. Intramuscular has the maximum number of pipeline products.
Ebolavirus Infections Pipeline Drugs Market Analysis, by RoA
To get more insights on key RoA, download a free sample report
Key Molecule Types in the Ebolavirus Infections Pipeline Drugs Market
The key molecule types in the Ebolavirus Infections pipeline drugs market are small molecule, monoclonal antibody, recombinant vector vaccine, subunit vaccine, antibody, vaccine, DNA vaccine, protein, antisense oligonucleotide, and gene therapy.
Ebolavirus Infections Pipeline Drugs Market, by Molecule Type
To get more insights on key molecule types, download a free sample report
Major Companies in the Ebolavirus Infections Pipeline Drugs Market
The major companies in the Ebolavirus Infections pipeline drugs market Mapp Biopharmaceutical Inc, Integrated BioTherapeutics Inc, Collaborations Pharmaceuticals Inc, Emergent BioSolutions Inc, Galactica Biotech Ltd, TFF Pharmaceuticals Inc, AIkido Pharma Inc, ANP Technologies Inc, BioComo Inc, and Celdara Medical LLC.
Ebolavirus Infections Pipeline Drugs Market, by Major Companies
For more company insights, download a free sample report
Ebolavirus Infections Pipeline Drugs Market Overview
Key Targets | Glycoprotein, RNA Directed RNA Polymerase, Cell Membrane, Ebola virus Matrix Protein VP40, Niemann Pick C1 Protein, RNA, 70 kDa Ribosomal Protein S6 Kinase, Cathepsin B, Cathepsin L1, and Cells Expressing Phosphatidylserine |
Key Mechanisms of action | Glycoprotein Inhibitor, RNA Directed RNA Polymerase Inhibitor, Cell Membrane Disruptor, Niemann Pick C1 Protein Inhibitor, RNA Synthesis Inhibitor, 70 kDa Ribosomal Protein S6 Kinase Inhibitor, Cathepsin B Inhibitor, Cathepsin L1 Inhibitor, Cytotoxic To Cells Expressing Phosphatidylserine, and Ebola virus Matrix Protein VP40 Inhibitor |
Key Routes of Administration | Intramuscular, Intravenous, Oral, Inhalational, Nasal, Parenteral, Subcutaneous, Topical, Intradermal, and Sublingual |
Key Molecule Types | Small Molecule, Monoclonal Antibody, Recombinant Vector Vaccine, Subunit Vaccine, Antibody, Vaccine, DNA Vaccine, Protein, Antisense Oligonucleotide, and Gene Therapy |
Major Companies | Mapp Biopharmaceutical Inc, Integrated BioTherapeutics Inc, Collaborations Pharmaceuticals Inc, Emergent BioSolutions Inc, Galactica Biotech Ltd, TFF Pharmaceuticals Inc, AIkido Pharma Inc, ANP Technologies Inc, BioComo Inc, and Celdara Medical LLC |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Ebolavirus Infections
- The pipeline guide reviews pipeline therapeutics for Ebolavirus Infections by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Ebolavirus Infections therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Ebolavirus Infections therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Ebola Hemorrhagic Fever
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective countercstrategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Ebola Hemorrhagic Fever
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Ebolavirus Infections pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
AIkido Pharma Inc
AlphaVax Inc
AnGes Inc
ANP Technologies Inc
AntoXa Corp
Arisan Therapeutics Inc
Auro Vaccines LLC
Bharat Biotech Ltd
BioComo Inc
BioCryst Pharmaceuticals Inc
BioFactura Inc
Biotron Ltd
Celdara Medical LLC
Chicago Biosolutions Inc
Cocrystal Pharma Inc
Collaborations Pharmaceuticals Inc
Emergent BioSolutions Inc
Emergex Vaccines Holding Ltd
Fab’entech SA
Fibroplate Inc
Flow Pharma Inc
Fox Chase Chemical Diversity Center Inc
Galactica Biotech Ltd
Gamaleya Federal Research Center of Epidemiology and Microbiology
GeoVax Labs Inc
Gilead Sciences Inc
Global BioLife Inc Ltd
Greffex Inc
H&P Labs Inc
ImmunityBio Inc
Inovio Pharmaceuticals Inc
Integral Molecular Inc
Integrated BioTherapeutics Inc
IntelliStem Technologies Inc
Johnson & Johnson
Mapp Biopharmaceutical Inc
Merck & Co Inc
Microbiotix Inc
Micropharm Ltd
Novavax Inc
Nykode Therapeutics AS
Oita University Institute of Advanced Medicine Inc
OncXerna Therapeutics Inc
Orgenesis Inc
Ostrich Pharma USA Inc
Palisades Therapeutics
PanThera Biopharma LLC
Phelix Therapeutics LLC
Phoenix Biotechnology Inc
Public Health Vaccines LLC
Regeneron Pharmaceuticals Inc
ReVacc Biotech
Riboscience LLC
Rodos BioTarget GmbH
SAB Biotherapeutics Inc
Secarna Pharmaceuticals GmbH & Co KG
Selva Therapeutics Inc
Sihuan Pharmaceutical Holdings Group Ltd
Soligenix Inc
TFF Pharmaceuticals Inc
Tiba Biotech LLC
Tonix Pharmaceuticals Holding Corp
Uvax Bio LLC
Vaxeal Holding SA
Vir Biotechnology Inc
XBiotech Inc
Xenothera SAS
Yaso Therapeutics Inc
Yisheng Biopharma Co Ltd
Zalgen Labs LLC
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Ebolavirus Infections pipeline drugs market?
In the Ebolavirus Infections pipeline drugs market the key targets are Glycoprotein, RNA Directed RNA Polymerase, Cell Membrane, Ebola virus Matrix Protein VP40, Niemann Pick C1 Protein, RNA, 70 kDa Ribosomal Protein S6 Kinase, Cathepsin B, Cathepsin L1, and Cells Expressing Phosphatidylserine.
-
What are the key mechanisms of action in the Ebolavirus Infections pipeline drugs market?
In the Ebolavirus Infections pipeline drugs market the key mechanisms of action are Glycoprotein Inhibitor, RNA Directed RNA Polymerase Inhibitor, Cell Membrane Disruptor, Niemann Pick C1 Protein Inhibitor, RNA Synthesis Inhibitor, 70 kDa Ribosomal Protein S6 Kinase Inhibitor, Cathepsin B Inhibitor, Cathepsin L1 Inhibitor, Cytotoxic To Cells Expressing Phosphatidylserine, and Ebola virus Matrix Protein VP40 Inhibitor.
-
What are the key routes of administration in the Ebolavirus Infections pipeline drugs market?
The key routes of administration in the Ebolavirus Infections pipeline drugs market are Intramuscular, Intravenous, Oral, Inhalational, Nasal, Parenteral, Subcutaneous, Topical, Intradermal, and Sublingual.
-
What are the key molecule types in the Ebolavirus Infections pipeline drugs market?
The key molecule types in the Ebolavirus Infections pipeline drugs market are Small Molecule, Monoclonal Antibody, Recombinant Vector Vaccine, Subunit Vaccine, Antibody, Vaccine, DNA Vaccine, Protein, Antisense Oligonucleotide, and Gene Therapy.
-
What are the major companies in the Ebolavirus Infections pipeline drugs market?
In the Ebolavirus Infections pipeline drugs market the major companies are Mapp Biopharmaceutical Inc, Integrated BioTherapeutics Inc, Collaborations Pharmaceuticals Inc, Emergent BioSolutions Inc, Galactica Biotech Ltd, TFF Pharmaceuticals Inc, AIkido Pharma Inc, ANP Technologies Inc, BioComo Inc, and Celdara Medical LLC. Mapp Biopharmaceutical Inc has the maximum number of pipeline products.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.